首页> EBioMedicine> Impact of insomnia on ovarian cancer risk and survival: a Mendelian randomization study.

Impact of insomnia on ovarian cancer risk and survival: a Mendelian randomization study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Heming,Wang

第一单位： Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.

作者： Heming,Wang ^[1] ; Brett M,Reid ^[2] ; Rebecca C,Richmond ^[3] ; Jacqueline M,Lane ^[1] ; Richa,Saxena ^[4] ; Brian D,Gonzalez ^[5] ; Brooke L,Fridley ^[6] ; Susan,Redline ^[1] ; Shelley S,Tworoger ^[7] ; Xuefeng,Wang ^[8]

作者单位： Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA. ^[1] Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA. ^[2] Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; NIHR Oxford Health Biomedical Research Centre, University of Oxford, Oxford, UK. ^[3] Center for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA. ^[4] Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA. ^[5] Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA; Children's Mercy Hospital, Kansas City, MO, USA. ^[6] Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. ^[7] Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA. Electronic address: xuefeng.wang@moffitt.org. ^[8]

关键词 Epithelial ovarian cancer Genome-wide association study Insomnia Mendelian randomization Patient survival The ovarian cancer association consortium